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Abstract
Most bacterial infections induce the activation of polymorphonuclear neutrophils (PMNs),
enhance their microbicidal function, and promote the survival of these leukocytes for pro-
tracted periods of time. Brucella abortus is a stealthy pathogen that evades innate immunity,
barely activates PMNs, and resists the killing mechanisms of these phagocytes. Intriguing
clinical signs observed during brucellosis are the low numbers of Brucella infected PMNs in
the target organs and neutropenia in a proportion of the patients; features that deserve fur-
ther attention. Here we demonstrate that B. abortus prematurely kills human PMNs in a
dose-dependent and cell-specific manner. Death of PMNs is concomitant with the intracel-
lular Brucella lipopolysaccharide (Br-LPS) release within vacuoles. This molecule and its
lipid A reproduce the premature cell death of PMNs, a phenomenon associated to the low
production of proinflammatory cytokines. Blocking of CD14 but not TLR4 prevents the Br-
LPS-induced cell death. The PMNs cell death departs from necrosis, NETosis and classical
apoptosis. The mechanism of PMN cell death is linked to the activation of NADPH-oxidase
and a modest but steadily increase of ROS mediators. These effectors generate DNA dam-
age, recruitments of check point kinase 1, caspases 5 and to minor extent of caspase 4,
RIP1 and Ca++ release. The production of IL-1β by PMNs was barely stimulated by B. abor-
tus infection or Br-LPS treatment. Likewise, inhibition of caspase 1 did not hamper the Br-
LPS induced PMN cell death, suggesting that the inflammasome pathway was not involved.
Although activation of caspases 8 and 9 was observed, they did not seem to participate in
the initial triggering mechanisms, since inhibition of these caspases scarcely blocked PMN
cell death. These findings suggest a mechanism for neutropenia in chronic brucellosis and
reveal a novel Brucella-host cross-talk through which B. abortus is able to hinder the innate
function of PMN.
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Author Summary
The absence of obvious clinical symptoms during the early stages of brucellosis is linked to
the Brucella stealthy strategy and its non-canonical PAMPs, which are low PRRs agonists.
Still, there are clinical profiles that require explanation. For instance −despite the fact that
neutrophils readily ingest Brucella during the onset of infection, brucellosis courses with-
out neutrophilia, and just a low number of infected neutrophils are present in target or-
gans. In the chronic phases, a significant proportion of the patients display absolute
neutropenia and bone marrow pancytopenia linked to the myeloid cell linage. Examina-
tion of the Brucella infected bone marrow reveals granulomas and phagocytosis of myeloid
cells. Based on these observations we explored the fate of native neutrophils during their
interaction with Brucella. We found that the bacterium induces the premature cell death
of neutrophils without inducing proinflammatory phenotypic changes. This event was re-
produced by the lipid A of the Brucella LPS and depends on NADPH-oxidase activation
and low ROS formation. We believe that this phenomenon explains −at least in part− the
hematological and histological profiles observed during brucellosis. In addition, it may be
that dying Brucella-infected neutrophils serve as “Trojan horse” vehicles for infecting
phagocytic cells without promoting activation.
Introduction
Polymorphonuclear leukocytes (PMNs) represent a key cellular component of the host’s anti-
bacterial arsenal. Once in the circulation, the average lifespan of PMNs is close to 5.4 days, pe-
riod after which they undergo spontaneous apoptosis [1]. This is in frank contrast to the
previously reported short lifespans of a few hours for these cells [2]. Then, these dead PMNs
are removed by phagocytic cells laying in the reticuloendothelial system, such as monocytes
(Mo), macrophages (Mϕ) and dendritic cells (DCs) [3]. This physiological phenomenon does
not induce proinflammatory signals and is regarded as a constitutive mechanism to maintain
leukocyte homeostasis [4].
Upon bacterial infection, PMNs are activated and migrate into tissues, where they may sur-
vive three to five days to perform their phagocytic, microbicidal and proinflammatory func-
tions [1,5]. These events are part of the innate immune response commonly triggered by
pathogen-associated molecular patterns (PAMPs) [6] or by danger signals that guide the
PMNs response [7].
A variety of microbes have evolved strategies to influence the timing and mode of PMN cell
death [8–10]. For instance, Shigella flexneri kills PMNs by necrosis, a process characterized by
the release of tissue-injurious granular proteins. This contributes to disruption of the intestinal
epithelial barrier, leading to the dysentery observed in shigellosis and allowing the bacterium to
enter its colonic host cells [11]. Similarly, Pseudomonas aeruginosa infections may cause lysis
or oncosis of PMNs, leading to persistent infections by depleting these cells and contributing to
the pulmonary pathophysiology by facilitating bacterial extracellular replication [12,13]. Oth-
ers, such as the obligate intracellular Anaplasma phagocytophilum and Chlamydia pneumoniae
are able to inhibit PMN cell death to achieve intracellular replication within these leukocytes
[14,15].
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Brucellamicroorganisms are stealthy alpha-protobacterial intracellular pathogens of mam-
mals, including humans [16,17]. In the early stages of infection, Brucellaminimizes the host
proinflammatory response, opening an immunological window that allows this bacterium to
invade and reach sheltered intracellular niches before adaptive immunity becomes effective
[16,18,19]. Once established, Brucella organisms survive and extensively replicate within the
intracellular milieu of Mo, Mϕ, DCs and placental trophoblasts [20,21]. As part of its parasitic
strategy, Brucella inhibits apoptosis and prolongs the life of these infected mononuclear phago-
cytic cells [16,22]. Although Brucella is readily internalized by PMNs [23,24], the bacterium
survives inside the phagosomes of these cells resisting their killing action including oxidative
components and isolated lysosomal extracts [16,25,26].
During the course of human and animal brucellosis, there are several clinical and pathologi-
cal features related to PMNs which biological mechanisms remain unclear. Among the most
striking signs are the neutropenia observed during chronic brucellosis, the absence of recruit-
ment of PMNs at the site of infection and the low numbers of Brucella infected PMNs in the
target organs [16,27–30]. Moreover, PMNs have an unexpected influence in dampening the
immune response against intracellular Brucella infection and strengthen the notion that PMNs
actively participate in regulatory circuits shaping both innate and adaptive immunity [19].
In an attempt to improve our understanding of the mechanisms underlying the fate of
PMNs during brucellosis, we have explored the outcome of these leukocytes upon interaction
with Brucella abortus. Our findings reveal a novel microbial-host cross-talk through which B.
abortus is able to hinder and evade host innate PMN response and suggest a mechanism by
which Brucellamay hamper the presence of infected PMNs in the target organs and promote
neutropenia during chronic brucellosis.
Results
B. abortus resists the killing action of PMNs
Confirming previous reports [16,18,31], Brucella is more resistant than other bacteria to the
killing action of PMNs (Fig 1A). This resistance is not related to reduced bacterial internaliza-
tion, since at multiplicity of infection (MOI) of 5, both B. abortus and Salmonella enterica,
were phagocytized at similar rates. Due to the toxic effects mediated by Salmonella on PMNs,
higher MOIs of this bacterium were precluded. Compared to latex beads, fluorescent B. abor-
tus-GFP was internalized more efficiently by PMNs at different MOIs, suggesting an active
PAMP receptor-mediated phagocytosis (Fig 1B). Early phagocytosis of B. abortus-GFP
(MOI< 50) was not accompanied by obvious PMN shape changes such as nuclear rounding,
chromatin condensation, cell fragmentation, degranulation (Fig 1C) or myeloperoxidase activi-
ty [16]. This observation is in agreement with previous reports [16,25,31,32]. Only when high
loads of B. abortus-GFP were tested (MOI> 50) changes in nuclear morphology was detected
in a proportion of PMNs containing more than 50 bacteria/cell (Fig 1C).
B. abortus infection induces PMN cell death in a dose-dependent
manner
After infection with Brucella-GFP, PMN cell death was assessed by flow cytometry using
Annexin V and AquaDead as markers. After two hours of incubation (MOI = 10), Brucella in-
fected PMNs (whole blood or purified PMNs, see below) became positive for both markers, fol-
lowing a bacterial dose dependence (Fig 2). This phenomenon did not require live bacteria,
since similar effects were observed in PMNs exposed to equivalent doses of live or heat killed B.
abortus (HKBA) (Fig 3).
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B. abortus releases Br-LPS inside vacuoles of PMNs
We have demonstrated that B. abortus sheds non-toxic Br-LPS inside cells and that this mole-
cule traffics in vacuoles and influences antigen presentation to T cells [33–35]. Following this,
we explored the shedding of Br-LPS inside PMNs by live B. abortus. For this purpose, we used
a double labeling fluorescence method [36]. First PMNs were infected with B. abortus-RFP at a
MOI of 5. After 1 h of incubation, PMNs were permeabilized and treated with anti-Br-LPS
FITC-antibody and counterstained with DAPI. This approach revealed that significant
amounts of Br-LPS molecules (green fluorescence) were released intracellularly by live (red
fluorescent) Brucella in the proximity of bacteria-containing PMN phagosomes (Fig 4). Almost
all B. abortus-RFP infected PMNs exhibited this pattern after 1 h infection, most strikingly evi-
dent by immunofluorescence in cells containing between 2–3 bacteria/PMN.
Fig 1. B. abortus is partially resistant to the killing action of PMNs. (A) PMNs were isolated from blood
and incubated with B. abortus or S. enterica (MOI 5) and CFUs determined at different time points. (B)
Heparinized blood was incubated with B. abortus-GFP or fluorescent latex beads for two hours (MOI 10 or
100). Blood smears were then fixed and mounted with ProLong Gold Antifade Reagent with DAPI. At least
100 PMNs were counted per sample and the number of intracellular bacterial or latex particles determined in
each PMN and the proportion expressed as % of phagocytized particles. (C) Human PMNs infected with
different MOI of B. abortus-GFP and stained as in “B”. Microscope images are at 400 × magnification.
Representative PMNs with DAPI-stained nuclei and intracellular green fluorescent B. abortuswere
photographed under the microscope using the appropriate color filter channel. Images were cut from
microscope field, contrasted and saturated using Hue tool to obtain suitable color separation. Images were
then merged using Adobe Photoshop 8 software. Experiments were repeated at least three times. Values of
p<0.01 (**) are indicated.
doi:10.1371/journal.ppat.1004853.g001
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In order to determine if Br-LPS was released inside vacuoles or translocated to the cytosol,
B. abortus infected PMNs were subjected to immunodetection of Br-LPS by electron microsco-
py. Regular osmium tetroxide staining of infected PMNs (1 hour) demonstrated that all phago-
cytized B. abortus reside inside phagosomes, and just a few of them within phagolysosomes,
confirming previous results [37]. As expected, sensitive staining for detection of immunogold
particles revealed the presence of Br-LPS in the bacterial cells. However, vesicles in the proxim-
ity of the ingested Brucella also contained gold particles, indicating the presence of Br-LPS
within vacuoles (Fig 5). In some cells, immunogold stained Br-LPS molecules were detected
within a phagosome containing partially digested bacteria or in the proximity of cell membrane
ruffle-like structures (Fig 5E). Gold particles were practically absent in the cytosol and not de-
tected in the extracellular milieu (Fig 5A).
Br-LPS specifically induces the cell death of PMNs
Intracellular Br-LPS influences the antigen presentation of Mϕ without affecting the survival of
these cells [34,35]. Therefore, we assessed the effects of Br-LPS on PMNs cell survival. As dem-
onstrated in Fig 6A, Br-LPS induced PMN cell death in a dose-dependent manner in blood or
in purified (see the results presented in the next sections) PMNs. This effect was specific for
PMNs since other cells, such as lymphocytes, treated and gated under the same conditions, did
Fig 2. B. abortus infection induces PMN cell death in a dose dependent manner. (A) Heparinized blood
was incubated with B. abortus-GFP (MOI 10) for two hours and PMNs population analyzed for cell death
using AquaDead and Annexin V markers. GFP fluorescence intensity was used to differentiate among three
categories: (a) low, (b) intermediate and (c) high infection. (B) Percentages of PMNs positive for any marker
in relation to the number of internalized bacteria are shown. Experiments were repeated at least three times.
doi:10.1371/journal.ppat.1004853.g002
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not display death cell markers (Fig 6B). Consistent with previous observations [22,38], Br-LPS
did not induce cell death of Mϕ, Mo and DCs. In contrast, Escherichia coli LPS (Ec-LPS) did
Fig 3. Live and heat-killed B. abortus induce PMN cell death.Heparinized blood was incubated with live
or heat-killed (HK) B. abortus for two hours (10 and 100 bacteria/PMN). PMN population was analyzed by
flow cytometry for cell death using AquaDead and Annexin V markers, as described in Fig 2. Percentages of
PMNs positive for any marker were determined. Experiments were repeated at least three times. No
significant differences were detected between live and HK B. abortus.
doi:10.1371/journal.ppat.1004853.g003
Fig 4. Br-LPS is released inside PMNs.Heparinized blood was incubated with B. abortus-RFP for one hour
(MOI 2). Blood smears were fixed, stained with anti-Brucella LPS FITC (green) and mounted with ProLong
Gold Antifade Reagent with DAPI. (a) B. abortus-RFP, (b) IgG-FITC anti-Brucella LPS staining, (c) PMN
DAPI staining and (d) merged images. Shed Brucella LPS (white arrow) is pointed. Representative PMNs
with DAPI-stained nuclei and intracellular B. abortuswere photographed under the microscope using the
appropriate color filter channel. Images were cut frommicroscope field, contrasted and saturated using Hue
tool to obtain suitable color separation. Images were then merged using Adobe Photoshop 8 program.
Microscope images are at 1000 × magnification.
doi:10.1371/journal.ppat.1004853.g004
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not induce cell death in blood (Fig 6A) or in purified PMNs under the same
experimental conditions.
In view of the relatively high amounts of Br-LPS added to induce PMN cell death, a quanti-
tative determination of the Br-LPS interacting with these cells was performed. For this purpose,
purified PMNs were incubated with Br-LPS and the associated amounts determined by West-
ern blotting (Fig 7). In order to have a saturating positive control, the assay was also performed
in the presence of human antibodies against Br-LPS. The estimated quantities of associated Br-
LPS in the absence of antibodies ranged between 5–25 ng/106 PMNs. Likewise, the amounts of
associated Br-LPS in the presence of antibodies were between 10–50 ng/106 PMNs. This result
indicates that the actual quantities of Br-LPS interacting with PMNs under these experimental
conditions corresponded just 0.05–0.25% of the total Br-LPS added. As expected, antibodies in-
creased close to 10 times the quantities of Br-LPS associated to PMNs through the concourse
of Fc receptors. It should be noticed that the molecules associated to PMNs corresponded to
the lower molecular weight (~30–40 MW) fraction of Br-LPS. This indicates that among all the
Br-LPS molecules available, just specific classes are selected by PMNs.
Fig 5. Br-LPS released inside cells is mostly found within vacuolar compartments of PMNs. Purified
human PMNs 5 ×106 were infected with B. abortus 2308 at MOI 20. After one hour incubation, infected cells
were fixed and processed for immunogold staining and electron microscopy. Detection of Br-LPS was
performed using mouse IgG anti Br-LPS in combination with protein-A/protein-G colloidal gold 15 nm. (A)
PMN (n, nucleus of cell) with intracellular B. abortus (white asterisk) and immunogold detection of Br-LPS. (B)
and (C) correspond to amplified sections pointed with arrows from “A” panel; B. abortus (white asterisk) and
immunogold detection of Br-LPS inside vacuoles (pointed by black arrow heads). (D) B. abortus (white
asterisk) within a phagosome (ph) and vacuoles containing immunogold labeled Br-LPS (black arrow heads).
(E) PMNmembrane ruffle showing immunogold detection of Br-LPS associated to the membrane (white
arrow heads) and B. abortus (white asterisk) debris inside a phagosome (ph) and immunogold detection of
Br-LPS inside vacuoles (black arrow heads). No colloidal gold particles were observed when IgG purified
from normal mouse serum was used for controlling the specificity of the reaction. Bar represents 500 nm.
doi:10.1371/journal.ppat.1004853.g005
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The lipid A moiety of the Br-LPS is responsible for the induction of PMN
cell death
The non-toxic Br-LPS is built of an O-chain constructed of N-formyl perosamine sugar homo-
polymer, a positively charged core oligosaccharide and a lipid A containing a diaminoglucose
disaccharide backbone substituted with long chain hydroxylated, cyclic and non-hydroxylated
fatty acids (S1 Fig). In an attempt to identify the moiety responsible for inducing the PMN cell
death, we first tested the biological action of different LPSs that shared at least some of the Br-
LPS structural features [18,39–45]: i) Yersinia enterocolitica O:9 LPS displays the same O-chain
homopolymer as Br-LPS but has different lipid A and core oligosaccharide; ii) Ochrobactrum
anthropi LPS shares the lipid A structural features with Br-LPS but possesses different O chain
and core oligosaccharide; iii) B. abortus ΔWadC LPS displays the same lipid A and O chain as
the Br-LPS, but has a different core oligosaccharide; finally, iv) the overall structure of Ec-LPS
Fig 6. Br-LPS induces cell death of PMN in a dose dependent manner. (A) Heparinized blood was
incubated with 100μg/mL of (a) Ec-LPS (corresponding to 7.5 pmol/mL) or (b) Br-LPS (corresponding to 3
pmol/mL) for two hours and the PMN population was analyzed by AquaDead and Annexin V markers as in
Fig 2. (c) Percentages of PMNs positive for any marker treated and with various concentrations of LPS are
shown. (B) Human blood was incubated with 3 pmol/mL of Br-LPS for two hours. (a) Lymphocyte and (b)
PMN populations were analyzed by AquaDead and Annexin V markers. (c) Percentages of lymphocytes and
PMNs positive for any marker treated and with various concentrations of Br-LPS for are shown. Experiments
were repeated at least three times. Values of p<0.01 (**) are indicated.
doi:10.1371/journal.ppat.1004853.g006
Brucella-Induced Neutrophil Cell Death
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differs from that of Br-LPS, but it shares the lipid A and core features with Y. enterocolitica O:9
LPS. As shown in Fig 8A, LPSs from B. abortus ΔWadC and O. anthropi sharing the same lipid
A structure as the Br-LPS were able to induce cell death more readily than other LPSs. A similar
pattern of PMN cell death was observed when these cells were treated with increasing quanti-
ties of purified B. abortus 2308 lipid A (Fig 8B). Altogether, these results demonstrate that the
lipid A of Br-LPS is the moiety responsible for inducing the premature cell death of human
PMNs.
Blocking of CD14 molecule prevents the Br-LPS-induced PMN cell
death
It is well known that the coordinated interaction of CD14, MD-2/TLR4 molecules mediate LPS
recognition in mammalian cells [46] and that binding of these membrane molecules may pro-
mote cell survival or cell death depending on the context [47,48]. Therefore, we explored the
roles of TLR4 and CD14 Br-LPS-induced the cell death in PMNs.
When TLR4 or CD14 receptors were blocked with specific antibodies prior to the exposure
of blood with Ec-LPS, the secretion of TNF-α was significantly abrogated (Fig 9A), indicating
that the amounts of antibodies used were suitable. Despite of the lower amounts of TNF-α in-
duced by Br-LPS as compared to those stimulated by Ec-LPS, the blocking of TLR4 does not
have any effect on the action of the former bacterial molecule on blood cells. This phenomenon
Fig 7. Quantities ofBr-LPS interacting with PMNs. The quantities of Br-LPS associated to PMNs were
determined byWestern blotting using a monoclonal antibody against Br-LPS conjugated with peroxidase
enzyme. All wells were loaded with 15 μL of the respective preparation. The amounts of purified Br-LPS in the
left panel were used to estimate the quantities based on a standard curve ranging from 0.06 ng to 12 ng (only
wells from 1.3–6 ng are shown). The right panel corresponds to the assay: purified PMNs were incubated with
Br-LPS and the associated amounts determined byWestern blot (Br-LPS+PMNs). In order to have a
saturating positive control, the assay was also performed in the presence of human antibodies against Br-
LPS (Br-LPS+PMNs+Ac). Controls included the assay performed with Br-LPS in the absence (C1) or
presence of human antibodies (C2) but in the absence of PMNs. PMNs alone did not show any signal. Notice
that the Br-LPS molecules associated to PMNs corresponded to the lower molecular weight fraction (~30–40
MW). The amounts of Br-LPS were estimated to be in the range of 5–25 ng/106 PMNs, corresponding to less
than 0.25% of the original Br-LPS added. The amounts of associated Br-LPS in the presence of antibodies
were between 10–50 ng/106 PMNs. These estimated quantities were from four different experiments. The
read-out of the corresponding bands was performed by densitometry.
doi:10.1371/journal.ppat.1004853.g007
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is consistent with previous findings demonstrating that Br-LPS is a poor agonist of the MD-2/
TLR4 pathway [16,43]. Likewise, when TLR4 was blocked, PMN cell death mediated by Br-LPS
was not inhibited (S2 Fig). In contrast, anti-CD14 antibodies significantly inhibited the secre-
tion of TNF-α (Fig 9A) in blood as well as PMN cell death induced by Br-LPS (Fig 9B). Since
anti-CD14 treatment of blood could modulate other leukocytes and influence the dead of
PMNs, we then performed the experiment using purified PMNs (Fig 9C) to confirm the block-
ing effect of anti-CD14. In preparations of purified human PMNs, blocking of CD14 totally
abolished the Br-LPS induction of cell death after a short incubation (Fig 9C). Anti-CD14
alone or low amounts of this antibody (1μg) did not have any observable effect in PMN
cell death.
Br-LPS-induced PMN cell death correlates with low ROS formation
The low and slow kinetics of ROS formation induced by Br-LPS correlates with the kinetics of
the PMN cell death observed (Fig 10A). Although it is dose dependent, this profile is in clear
Fig 8. Brucella lipid A induces PMNs cell death in a dose dependent manner. (A) Heparinized blood was
incubated for two hours with LPSs of Y. enterocoliticaO:9 (3 pmol/mL), of E. coli (7.5 pmol/mL), of B. abortus
2308 (3 pmol/mL), of B. abortus ΔWadC (3 pmol/mL) and ofO. anthropi (2 pmol/mL), all corresponding to
100μg/mL of LPS. The LPSs differed in at least one of the moieties (O-chain, core and lipid A) with B. abortus
2308 LPS: (a) LPSs possessing lipid As that differ from B. abortus 2308 LPS, (b) LPSs possessing lipid As
structures similar to B. abortus 2308 LPS. (B) Heparinized blood treated with different concentrations of B.
abortus 2308 lipid A for two hours. In all assays, PMN population was gated and analyzed by Annexin V
marker and the geometric means of histograms displayed as relative units. Experiments were repeated at
least three times.
doi:10.1371/journal.ppat.1004853.g008
Brucella-Induced Neutrophil Cell Death
PLOS Pathogens | DOI:10.1371/journal.ppat.1004853 May 6, 2015 10 / 29
Fig 9. Neutralization of CD14 protects againstBr-LPS-induced PMN cell death. (A) Heparinized blood
was incubated for two hours with 0.4 pmol/mL of Ec-LPS or 3 pmol/mL of Br-LPS. Prior to LPS stimulation,
some samples were previously treated with anti-TLR4 (1 μg/mL) or anti-CD14 (5μg/mL) antibodies and TNF-
α secretion quantified in plasma by ELISA. Values of p<0.01 (**) are indicated in relation to their respective
LPS control. (B) Heparinized blood was incubated with Br-LPS (3 pmol/mL) alone or previously neutralized
with different quantities of anti-CD14. PMN population was gated and analyzed by Annexin V marker.
Geometric means of histograms displayed as relative units. Experiments were repeated at least three times.
(C) Purified PMNs were incubated for two hours with Br-LPS (1.5 pmol/mL). Prior to LPS stimulation, some
samples were previously treated with anti-CD14 (5μg/mL) antibodies and PMN population gated and
analyzed by AquaDead marker. Anti-CD14 alone does not have any significant effect in PMN cell death.
Value of p<0.01 (**) is indicated in relation to the Br-LPS control.
doi:10.1371/journal.ppat.1004853.g009
Brucella-Induced Neutrophil Cell Death
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Fig 10. Br-LPS-induced PMN cell death correlates with low ROS formation. Purified human PMNs were seeded on serum-uncoated plates and treated
with various concentrations of Br-LPS or Ec-LPS for 6.5 h. (A) ROS kinetics production was monitored for 90 minutes by luminol-amplified
Brucella-Induced Neutrophil Cell Death
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contrast and opposite to the kinetics of ROS formation and cell death measured in Ec-LPS
treated PMNs (Fig 10B). Brucella-infected PMNs did not undergo NETosis or display typical
signs of apoptosis or necrosis (Fig 1C). Likewise, the doses of Br-LPS that promoted PMN cell
death failed to induce NETosis (S4 Fig) or degranulation, as demonstrated before [49]. There-
fore, this phenomenon seems to be specifically mediated by Br-LPS and its lipid A. This also
agrees with previous data demonstrating that these bacterial molecules barely induce degranu-
lation or activation of PMNs [49].
Br-LPS triggers PMN cell death through the action of NADPH-oxidase
and ROSmediators
Many of the cell death features displayed by PMNs are unique for these leukocytes [50–52].
Since microscopically the Brucella-induced PMN cell death does not fit with any of the classical
cell death types described for these phagocytes, then we investigated the action of several chem-
ical inhibitors (Fig 11). Among the most conspicuous were the NADPH-oxidase inhibitor,
acetovanillone (apocynin) [53] and the superoxide and hydrogen peroxide scavengers, tiron
and catalase, respectively [54,55]. These chemicals almost completely abrogated the Br-LPS-in-
duced PMN cell death.
Since inhibition of the check point kinase 1 (Chk1) significantly prevented the cell death of
Br-LPS treated PMNs, then we explored the induction of DNA damage. One hour after B.
abortus infection, the fragmentation of PMN DNA was already evident (S5A Fig). The DNA
damage induced by B. abortus infection or by Br-LPS treatment was reversed by pan-caspase
inhibition (S5B Fig), suggesting the participation of caspase-activated DNase (CAD) [56].
Blocking of caspase 5 and to minor extent of caspase 4, prevented cell death; however, spe-
cific inhibition of caspases 1 had very little effect. Although related to caspase 1, caspases 5 and
4 have different substrates than caspase 1, and the activation of the former caspases induce cell
death independently from the later [57]; therefore not necessarily linked in function. This re-
sult, suggests the absence of inflammosome recruitment in the Brucella induced PMNs cell
death. The modest action of BAPTA/AM and Necrostatin-5 indicates partial involvement of
Ca++ and the RIP1 kinase/FADD cell death routes [58].
Caspase-8 and caspase-9 are important mediators of cell death through the extrinsic and in-
trinsic pathways [59,60]. As shown in Fig 12, both caspases became activated after treatment of
PMNs with Br-LPS. In spite of this, specific inhibitors for these caspases had little effect in pre-
venting the death of PMNs (Fig 11). This effect was specific for PMNs since caspase triggering
was not observed in other blood cells, such as lymphocytes (S3 Fig). This suggests the down-
stream recruitment of caspases 8 and 9, after the initial cell death triggering mechanisms.
Other inhibitors, such as those used for preventing necrosis, apoptosome formation or the ac-
tivity of Ca++ dependent-ATPase or MAP-, tyrosine- or PI3-kinases did not have any effect in
blocking the action of Br-LPS (Fig 11).
Brucella and Br-LPS induce low levels of proinflammatory cytokines in
PMNs
Pro-inflammatory TNF-α, IL-1β and IL-6 cytokines and IL-8 chemokine, may influence the
life of PMNs, either prolonging or inducing the death of these phagocytic leukocytes [61–64].
chemiluminescence and the maximum obtained value for each LPS concentration plotted (black line). (B) Cell death of purified PMNs was monitored by
evaluation of Sytox green fluorescence (shown as percentage of cell death relative to PMA-induced cell death) (red dotted line). Figure represents the
outcome of a single experiment. Similar results were obtained in repeated experiments. Correlation R2 was obtained by using the Excel tool facility.
doi:10.1371/journal.ppat.1004853.g010
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Therefore, we assessed the release of these cytokines and chemokines in whole blood cell prepa-
rations or purified PMNs after Brucella or Br-LPS treatment. S. enterica was included as a
Fig 11. Inhibitory action of various compounds on the Br-LPS-induced PMN cell death. Prior to Br-LPS
stimulation, samples were treated with wortmanin (50 nM), genistein (100 μM), IM-54 (10 μM), tyrphostin
(250 μM), thapsigargin (50 nM), NS3694 (10 μM), PD098059 (50 μM), Z-YVAD-FMK (10 μM), Z-LEHD-FMK
(10 μM), necrostatin-5 (10 μM), Z-LEVD-FMK (10 μM), BAPTA/AM (10 μM), Z-IETD-FMK (10 μM),
Z-WEHD-FMK (10 μM), YVAD-CHO (50 μM), Z-VAD-FMK (10 μg/mL), AZD7762 (30 μM), catalase (2800 U/
mL), tiron (2 mg/mL), acetovanillone (100 μg/mL) or PBS. After treatment with the inhibitory compounds,
samples were incubated with Br-LPS (1.5 pmol/mL) for 2 hours. Samples were further processed and
analyzed by cytometry for cell death with Annexin V as described above. Geometric means of histograms
displayed as relative units. In the upright corner, the read out procedure of the inhibitory action of tiron,
catalase and acetovanillone is presented. Values were estimated as relative units of the geometric means of
histograms. Each experiment was repeated at least three times.
doi:10.1371/journal.ppat.1004853.g011
Fig 12. Br-LPS induces activation of caspase 8 and 9 in PMNs. (A) Heparinized blood was incubated with 0.3 pmol/mL of Br-LPS or PBS for 30 minutes
and stained with anti-active caspase 8 or anti-active caspase 9. PMNs population was analyzed by each caspase marker (B) Heparinized blood samples
were treated with Z-VAD-FMK or PBS for 1 hour and then incubated with Br-LPS (1.5 pmol/mL) for 2 hours. PMNs population was analyzed by Annexin V.
Geometric means of histograms are displayed as relative units. Experiments were repeated at least three times.
doi:10.1371/journal.ppat.1004853.g012
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control. As shown in Fig 13, there were significant quantitative differences in cytokine produc-
tion between blood and purified PMNs. Salmonella stimulates the release of cytokines by
PMNs (Fig 13), induces degranulation and does not prematurely promote the cell death of
these cells [65] Regardless whether blood or purified PMNs were tested, the levels of TNF-α,
IL-1β and IL-6 were comparatively low after Brucella infection or Br-LPS treatment. This result
is consistent with the low cytokine production by Brucella infected or Br-LPS treated macro-
phages [66–69], or by Brucella infected mice at early time points of infection [16].
The concentrations of IL-8 induced by Brucella or Br-LPS in purified PMNs were signifi-
cantly higher than the levels of the other cytokines (Fig 13). This is striking since it has been es-
tablished that the chemoattractant IL-8, rather than inducing cell death, promotes PMNs
Fig 13. Cytokine differences between blood and purified PMNs infected with B. abortus or stimulated
with Br-LPS. The level of the indicated cytokines was determined by ELISA in the plasma of heparinized
blood or in the culture supernatants of purified PMNs after treatment with S. enterica, B. abortus or Br-LPS at
various concentrations for two hours. Experiments were repeated at least three times.
doi:10.1371/journal.ppat.1004853.g013
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survival [61,70]. Transcription of IL-8 is constitutive in PMNs, making the synthesis of this
chemokine readily available after simulation [71]. Still, the cell death remains evident in both
PMN preparations, being more conspicuous in blood that in purified PMNs.
Discussion
The consensus in Gram negative bacterial infections is that the endotoxic LPS molecule and
other PAMPs, engage PMNs into activation and prolongation of their life span [63]. This phe-
nomenon is linked to the activation of other cells such as Mϕ, Mo and DCs. In purified PMNs,
stimulation of TLR2 and TLR4 with agonists modestly inhibits apoptosis, while in the presence
of Mϕ, Mo and DCs, the inhibition of PMN cell death is very potent [47,72]. PMNs are able to
use this time delay to recruit other cells and to promote proinflammatory events to eliminate
the invading bacteria [73] through actions that involve the respiratory burst [5]. It has been
shown that high levels of ROS inhibit caspases activities, suggesting that reactive oxygen species
may prevent these proteases from functioning optimally in PMNs [74]. During these processes,
some PMNs degranulate, others undergo NETosis, while others may die by necrosis or oncosis,
triggering proinflammatory signals [51,52].
In contrast, upon invasion Brucella resists the killing action of PMNs and prematurely in-
duces the cell death of these phagocytes. The Brucella-induced PMN cell death occurs without
bacterial replication [23,24] and without promoting those classical phenotypic changes associ-
ated with NETosis, degranulation, necrosis, oncosis or classical apoptosis. The cell death of
Brucella-infected PMNs seems to be triggered after active phagocytosis of the microorganism
followed by the intracellular release of the Br-LPS inside cell vacuoles, either by alive or death
bacteria. Although the process by which B. abortus sheds Br-LPS inside the cells has not been
elucidated, it is likely that it occurs through blebbing of outer membrane fragments enriched in
Br-LPS, a phenomenon that is well known in Brucella [75]. This is significant, since Br-LPS is
capable to circulate in the body and reside inside phagocytes for months without being de-
stroyed [33], and consequently, capable to exert its biological action on PMNs in vivo.
There are reports claiming that B. abortus and Brucella lipoproteins activate PMNs [76].
However, in those experiments the ex vivo PMNs viability was less than expected and the as-
says were performed with heat killed bacteria and lipoproteins acylated in the E. coli back-
ground; thus preventing comparison with our results, as explained before [17]. The interaction
between the lipid A of Br-LPS and PMNs mostly precludes TLR4, as well as other TLRs, as
demonstrated before for Mϕ [18,43,67,77,78]. However, it does not exclude the CD14 mole-
cule, since antibodies against the later co-receptor abrogates the PMN cell death and to less ex-
tent the release of TNF-α, suggesting some signaling through this co-receptor. The interaction
of Br-LPS with intracellular CD14 molecules is feasible, since this lipoprotein is also found in-
side PMN vesicles [79] and in concordance with the transport of Br-LPS to CD14 containing
lipid rafts in Mϕmembranes [80]. Moreover, in agreement with our results, it has been shown
that in Mϕ, Brucella signals through CD14 for the production of low amounts of TNF-α [81].
Finally, the involvement of CD14 in the induction of cell death is not without precedent and it
has been demonstrated that direct binding of LPS to CD14 −without the concourse of TLR4−
prompts apoptosis in DCs [48].
We have demonstrated in murine Mϕ that Br-LPS follows the classical endocytic pathway
used by protein antigens but with a slower kinetics [80]. Then, Br-LPS is transported to cellular
compartments enriched in MHC-II and recycled to the cell surface, where it forms dense
macrodomains. Once in the cell membrane, the Br-LPS macrodomains segregate several lipid-
raft components and interfere with the MHC-II presentation of peptides to specific CD4+ T
cells [80]. The initial release of Br-LPS inside PMN phagosomes and its subsequently transit
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within vacuoles seems to occur by a similar mechanism proposed for Mϕ [82]. Likewise, in
some infected PMNs, Br-LPS was also observed in cell membrane ruffles-like structures. How-
ever, the biogenesis and life span between infected human PMNs and murine Mϕ is rather dif-
ferent: while in the former leukocytes Brucella induces premature cell death, in the later it
prologues the life span and protects against apoptosis [16,22]. Moreover, the amounts of Br-
LPS internalized by Mϕ are comparatively much higher than those ingested by PMNs [33].
This difference may be linked to the numbers of CD14 surface molecules present in Mo and
Mϕ, which are from 30–40 times more abundant than in PMNs [83]. However, the amounts of
intracellular Br-LPS available in PMNs at early times of cell infection may be considerably larg-
er than in Mϕ; since the former leukocytes ingest larger number of Brucella organisms than the
latter, which internalize just a few bacteria [84]. These and other differences make quite diffi-
cult to perform a detail experimentation of the intracellular trafficking of Br-LPS inside PMNs,
and alternative methodological approaches would be required. For the moment, this is beyond
of our possibilities.
The dose-dependent Br-LPS-induced PMN cell death correlates with a modest but steadily
increase of ROS mediated by NADPH oxidase. This seems to be the main triggering mecha-
nisms by which the lipid A of Br-LPS induces the premature cell death of human PMNs. It is
worth noting that several of the molecular pathways causing PMN cell death are dependent on
ROS generation. While large amounts of ROS may inhibit caspases, promote necrosis or cause
NETosis [74,85,86], low amounts may induce PMN cell death [52].
DNA damage by oxygen radicals is a well-known phenomenon in a variety of cells, includ-
ing PMNs [52]; and even small amounts of ROS may induce DNA alterations. The recorded
DNA fragmentation of B. abortus and Br-LPS treated PMNs recruited Chk1, a protein that co-
ordinates the DNA damage response at the initiation of cell cycle [87]. Although in other cells
inhibition of Chk1 induces apoptosis [87], it is likely that in non-dividing cells −such as PMNs
− this protein has a terminal role and its function is not to arrest the cell cycle, but to promote
cell death. The PMN DNA fragmentation was partially reversed by pan-caspase inhibitors;
event that suggests the participation of CAD [56].
At first glance, the profile of inhibitory substances suggests that caspase-8 could be extrin-
sically activated through the RIP1 kinase/FADD route [88]. In addition, the mobilization of
Ca++ may activate several death signals, including the calcium-activated cysteine protease cal-
pain that cleaves and thereby activates a number of molecules that have important functions in
the apoptosis processes [89].
As already recorded in human monocytes [68] the amounts of IL-1β induced by B. abortus
and its Br-LPS in PMNs are rather low. In addition, inhibition of caspase 1 did not block the
Br-LPS mediated PMN cell death. These two observations, together with the low cytokine in-
duction by Brucella and its Br-LPS in PMNs, seem to preclude the role of the inflammasome
pathway in the premature death of these leukocytes. Though this seems relevant, it has been re-
ported that caspase-1 induced pyroptotic cell death does not function in PMNs [90]. Moreover,
upon inflammasome activation the amounts of IL-1β produced by purified PMNs are rather
low [91]. This may be linked to the fact that human neutrophils express key components of the
inflammasome machinery at non-canonical intracellular sites [91]. A general proposal of the
mechanisms for the induction of the premature PMN cell death generated during B. abortus in-
fection is presented in S6 Fig.
It is well known that under certain circumstances, proinflammatory cytokines produced by
leukocytes during Gram negative endotoxemia are capable of inducing programmed cell death
[92,93]. Among these, the TNF-α is the most conspicuous cytokine generating apoptosis
through binding to its cognate TNFR1 [94,95]. However, it is unlikely that TNF-α is the signal
that promotes the Br-LPS-induced PMN cell death. First, the amounts of proinflammatory
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cytokines −including TNF-α− produced upon exposure of PMNs to Brucella or Br-LPS were
very low (Fig 13). Second, it is well known that Brucella and Br-LPS are low agonist of pattern
recognition receptors and low activators of NF-κB [16,43,67]. Third, under similar experimen-
tal conditions the Ec-LPS −which induces the production of much higher quantities of TNF-α
− does not promote premature PMN cell death (Figs 6A and 9). Finally, under the same experi-
mental conditions Br-LPS did not induce the death of lymphocytes (Fig 6B) which are also sus-
ceptible to the pro-apoptotic effect of TNF-α [95].
It is worth noting that the amounts of IL-8 induced by B. abortus in purified PMNs were
higher than other cytokines. It has been shown that this chemokine, rather that promoting cell
death, delays spontaneous and TNF-α-induced apoptosis of human PMNs in a dose dependent
manner [70]. The delay in apoptosis is mainly mediated through the interaction of IL-8 with its
cognate RII receptor, while the RI receptor may provide an added effect. Still, PMNs died after
Brucella infection or Br-LPS treatment, precluding the influence of IL-8 in a delimited popula-
tion of PMNs. The different levels of cytokines detected in whole blood versus purified PMNs
exposed to Brucella or Br-LPS may reflect the participation of Mo, DCs and serum components
(e.g. complement) present in blood, which may have served as an additional stimuli and
sources of cytokines, including IL-8.
For many years it has been recognized that a proportion of patients with chronic brucellosis
display absolute neutropenia [27,28]. It has been also shown that the invasion of Brucella or-
ganisms induces significant hematological chages in the bone marrow, involving pancytopenia
and phagocytosis of blood elements (including PMNs) by resident Mϕ [96–98]. In addition,
during the accute phase of brucellosis there is a conspicuous absence of infected PMNs in the
target organs, a phenomenon that is in clear contrast to the presence of Brucella inside Mϕ and
DCs [29]. The fact that Brucella and its Br-LPS specifically induce the premature cell death of
PMNs may explain, at least in part, these clinical signs.
Dying PMNs display “eat-me” signals. Therefore, they are readily removed by phagocytic
cells. Then, it is likely that Brucella infected PMNs may serve as “Trojan horse” vehicles for dis-
persing the bacterium to other organs; hence, contributing to the long lasting infections ob-
served in brucellosis [99]. The Brucella-induced cell death −without significant activation of
PMNs and their non-phlogistic removal by Mϕ and DCs− would help to hamper the promo-
tion of proinflammatory signals (S7 Fig). This mechanism may represent a seminal component
of the stealthy strategy used by Brucella organisms [16] to spread in its host while avoiding
innate immunity.
Materials and Methods
Ethics
Human fresh blood was obtained in the blood bank of the Charité Hospital, Berlin, following a
protocol approved by the Charité Hospital, Berlin Ethical Committee. Fresh blood was also ob-
tained from normal healthy volunteer donors through the “Etablissement Français du Sang”
following their approval and in agreement with the “French Ethics Committee on Human Ex-
perimentation F11”, within a convention EFS-08-21-2012 with Institut National de la Santé et
de la Recherche Médicale, signed. All blood donors involved were informed about the study
and provided written consents.
Bacterial strains, LPSs and lipid A preparations
Virulent B. abortus (2308), B. abortus-GFP (2308) [100], transgenic B. abortus-RFP (2308)
with an integrated chromosomal gene coding for the red fluorescent protein from Discosoma
coral (provided by Dr. Jean-Jacques Letesson; Unité de Recherche en Biologie Moléculaire,
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Facultés Universitaires Notre-Dame de la Paix, Namur, Belgium) and Salmonella enterica sv.
Typhimurium (SL1344) were grown in tryptic Soy or Luria Bertani broths as previously de-
scribed [16]. Bacterial cells were washed three times by centrifugation in Hanks or PBS solution
before the assays. Purified LPSs were prepared from B. abortus (2308), B. abortus wadC (2308),
E. coli (0127), Y. enterocolitica O:9 (MY79), O. anthropi (LMG 3331T) as reported before
[43,77]. B. abortus lipid A was prepared by mild acid hydrolysis from Br-LPS and solubilized as
described elsewhere [101]. All the Brucella Br-LPS and lipid A preparations were above 98%
pure and devoid of contaminant proteins, free lipids and cyclic glucans.
Neutrophil purification
PMNs were purified by Histopaque and Percoll gradients from blood of healthy donors as pre-
viously described [16,50]. Cell preparations were composed from 95–98% of granulocytes. Cell
viability was>90%. PMN preparations were maintained at 4°C in PBS or autologous plasma,
and used within the first hour after extraction. Under our conditions, PMN spontaneous apo-
ptosis was just evident after 5–7 hours after purification.
Bactericidal activity
Bactericidal activity was measured as previously described [16]. Briefly, B. abortus or S. enterica
were mixed with 500 μL of purified human PMNs (1x106 PMNs/mL) at a MOI of 5 bacteria/
PMN and incubated under mild agitation for 90 minutes. Control bacteria were incubated in
the absence of PMNs to quantify bacterial replication during the experiment. Viable CFU were
determined at 0, 45 and 90 minutes of incubation by lysing cells with 0.1% triton and plating
samples in tripticase soy agar. The percentage of bacterial survival was calculated.
Phagocytosis assay
Human heparinized blood or purified PMNs were incubated with B. abortus-GFP or fluores-
cent latex beads for two hours at 37°C a multiplicity of infection (MOI) of 10–100 bacteria or
beads/cell, under mild agitation. Smears were fixed with methanol and mounted with ProLong
Gold Antifade Reagent with DAPI. One hundred PMNs were counted per sample and the
number of particles determined to calculate the percentage of phagocytosis.
PMN cell death assays
PMN cell death was analyzed by treating human whole blood or isolated PMNs with different
bacterial strains and LPSs. Human heparinized blood (100 or 500 μL) collected with lithium
heparin was incubated for 2 hours at 37°C in agitation (200–300 rpm) with each treatment.
Bacteria were tested at MOIs of 1, 10 or 100 bacteria/PMN. In the case of LPS or lipid A, blood
samples were treated at concentrations from 3x10-3 to 3x101 pmol/mL. After incubation, blood
samples were lysed for 5–10 min in 900 μL of red blood cell lysis buffer (NH4Cl 8.02 gm,
NaHCO3 0.84gm and EDTA 0.37gm/L, pH 7.2). Cells were washed with ice cold PBS and re-
suspended in 100 μL of Annexin V Binding Buffer (BD). 5 μL of Annexin V (BD) and 2 μL of
AquaDead (Invitrogen) (diluted 1/20 in PBS) were added and incubated for 30 min on ice in
the dark. Cells were washed once with ice cold PBS, re-suspended in 200 μL of paraformalde-
hyde 3% and incubated for 30 min at room temperature. Samples were then diluted 1:2 with
PBS and acquired for analysis within 1 hour.
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Intracellular detection of Br-LPS
For intracellular detection of Br-LPS a double labeling fluorescence approach was performed
[36]. Human heparinized blood was incubated with B. abortus-RFP (red) for one hour (MOI
2) under mild agitation. Blood smears were fixed and permeabilized with methanol, stained
with anti-Brucella LPS FITC (green) and mounted with ProLong Gold Antifade Reagent with
DAPI (blue). Samples were observed by fluorescent microscopy (Olympus BH-2) under
1000 × magnification. Br-LPS shed by Brucella is shown in green staining around red bacteria.
Intracellular detection of Br-LPS was also performed in B. abortus infected PMNs by immu-
nogold detection under the electron microscope. Briefly, purified human PMNs 5 ×106 were
infected with B. abortus 2308 at MOI 20. After 1 hour incubation at 37°C under mild agitation,
cells were washed and the pellet fixed with 200 μl of 2.5% glutaraldehyde in phosphate buffer
0.05M pH 7.4 (PB) at 4°C for 1 hour. Cells were pelleted at 3000 rpm for 10 min, washed in PB
and suspended in 50 μL of PB. Then fixed cells were incubated at 40°C for 5 minutes, and
100 μL of 3% low melting agarose at 40°C added. The temperature was lowered, and 5 volumes
of 2.5% glutaraldehyde in PB were added to the solid agarose block and incubated overnight at
4°C. Agarose blocks containing the fixed infected PMNs were processed for inclusion in Spurr
resin for immunogold staining and for electron microscopy as described elsewhere [102]. For
detection of Br-LPS, human IgG or mouse IgG with specificity against the O chain polysaccha-
ride [103] were used in combination with protein-A/protein-G colloidal gold 15 nm (EY Labo-
ratories, Inc.). Purified mouse and human IgGs from normal serum were used for controlling
the specificity of the reaction. Finally, PMNs sections were stained following the led citrate pro-
cedure described by Reynolds [104] [101] and observed under a Hitachi H 7100
electron microscope.
Quantitation of Br-LPS interacting with PMNs
In order to determine the amount of Br-LPS interacting with human PMNs, 10 μg (0.3 pmol)
of Br-LPS were incubated with 1x106 PMNs in 500 μL of HBSS at 37°C for 1 h under mild rota-
tion in the presence or absence of human IgG anti-Br-LPS. PMNs were washed three times
with HBSS to remove the excess of Br-LPS, and then the cell pellet lysed with deionized water
containing 50 μg/mL of DNAase and 125 μg/mL of proteinase K (Fisher Scientific) at 37°C for
1 h under mild rotation. Cell lysate was incubated with SDS-PAGE sample buffer and subjected
to Western blotting. Br-LPSs bands were revealed with a monoclonal antibody against the O
chain polysaccharide of the Br-LPS conjugated with peroxidase [105]. Controls included the
assay performed with Br-LPS in the absence or presence of human antibodies but in the ab-
sence of PMNs, and PMNs alone. Quantitation of Br-LPS bound to PMNs was estimated in re-
lation to a standard curve of purified Br-LPS ranging from 0.1 ng to 12 ng. The read-out of the
bands was performed by densitometry with the support of ImageJ software (http://imagej.net).
ROS detection
Isolated PMNs (1x105) were re-suspended in 50 μL of Hanks Balanced Salt Solution (HBSS
+1% FBS) per well of a 96-uncoated serum well plate. Cell suspension was supplemented with
Reactive Oxygen Species (ROS) Detection Reagents (Invitrogen) and stimulated with phorbol
myristate acetate (40 nM), Br-LPS (0.03–3 pmol/mL), Ec-LPS (0.09–7.5 pmol/mL) in 50 μl
HBSS+1% FBS or left untreated. The kinetics of ROS production was monitored with a Victor
Perkin Elmer luminometer at 37C for 90 min.
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NET formation and cell cytotoxicity assay
Isolated PMNs (1x105) were re-suspended in 500 μL of RPMI medium (10 mMHEPES +1%
FBS without glutamine) and let sit on 24-well plates for 30 min at 37°C. Cells were stimulated
with phorbol myristate acetate (40 nM) (Sigma), Br-LPS (0.7–100 μg/ml), Ec-LPS (0.7–100 μg/
ml) or left untreated in RPMI medium. After 6h 30 minutes, cell cytotoxicity was measured by
Sytox (0.3 μM) (Invitrogen) staining with a fluorometer. Some cells were fixed in paraformal-
dehyde 8% and observed with a Leica inverted fluorescence microscope to evaluate the nuclear
morphologies and NET spreading.
Cytokine quantitation
The levels of TNF-α, IL-8, IL-1β and IL-6 were measured by ELISA (eBioscience) in heparin-
ized human blood (plasma) or supernatant of isolated PMNs treated with different stimuli ac-
cording to manufacturer’s specifications.
Determination of caspase 8 and 9 activation
Heparinized human blood (500 μL) was incubated with B. abortus LPS (10 μg/mL) or PBS for
30 minutes under mild agitation and stained directly and incubated with anti-active caspase 8
or anti-active caspase 9 using Guava Caspase 8 FAM & Caspase 9 SR Kit (Millipore) according
to manufacturer’s specifications and quantitated by flow cytometry. PMNs population was
gated by forward light scatter and side light scatter parameters and analyzed by each
caspase marker.
DNA fragmentation assays
PMNs were isolated as previously described [106] and incubated for one hour with B. abortus
(MOI 100) or 10 μg/mL (0.3 pmol) of Br-LPS in the presence or absence of a pan-caspase in-
hibitor (Z-VAD-FMK). Cycloheximide (Sigma-Aldrich) was used as a positive control for
DNA fragmentation. After incubation, PMN cell death was measured by using a DNA frag-
mentation ELISA (Roche) according to manufacturer’s specifications. For microscopic analy-
sis, heparinized blood was incubated with B. abortus-RFP for 2 hours (MOI 100). Red blood
cells were lysed and total leucocytes prepared, fixed and stained with APO-BrdU TUNEL
Assay Kit (Invitrogen) according to manufacturer’s specifications. Cells were centrifuged on a
microscope slide by using a Cytospin 2 (Shandon) and mounted with ProLong Gold Antifade
Reagent with DAPI (Invitrogen).
TLR4 and CD14 neutralization
TLR4 and CD14 cell receptors were neutralized (before Br-LPS or Ec-LPS treatments) by incu-
bating isolated PMNs or heparinized human blood with 1 μg of anti-hTLR4-IgG (clone
W7C11) or 5 μg of anti-CD14-IgA (clone D3B8) antibodies (InvivoGen), for 20 minutes and
one hour respectively. No inhibitory or stimulatory signals were observed with mouse mono-
clonal IgG1 (anti-bovine IgG, Sigma-Aldrich), or enriched mouse and human immunoglobulin
preparations. Receptor blockage was verified in side controls by measuring TNF-α secretion
after treating blood with 5 μg/mL Ec-LPS (Fig 9A).
PMN cell death inhibition assays
Heparinized human blood samples (350 μL) were pre-incubated with one of the following
compounds for 1 hour: IM-54 (Enzo Life Sciences), Wortmanin, Genistein, Tyrphostin,
PD098059, Necrostatin-5, Z-VAD-FMK, AZD7762, Catalase, Tiron, Acetovanillone (Sigma),
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BAPTA/AM, YVAD-CHO, NS3694, Thapsigargin (Calbiochem), Z-IETD-FMK,
Z-WEHD-FMK, Z-LEVD-FMK, Z-LEHD-FMK (BioVision), Z-YVAD-FMK (Santa Cruz).
Concentrations were utilized according to previous reports and standardized to our conditions
for optimal inhibitory performance. After treatment with the inhibitory compounds, samples
were incubated with Br-LPS (1.3 pmol/mL) for 2 hours. Samples were further processed and
analyzed by cytometry for cell death with Annexin V as described above.
Flow cytometry and FACS analysis
PMN or lymphocyte populations were gated as indicated (S8 Fig) and analyzed for cell death
of caspase activation by flow cytometry. FACS analysis was performed using a FACSCanto sys-
tem (BD Biosciences) or Guava easyCyte (Millipore). FACS data were analyzed using FlowJo
software (Tree Star, Inc.). For each experiment, control samples were included to define the
proper gates.
Statistical analysis
Values were expressed as means ± standard error, and compared using Student’s t test for de-
termining the statistical significance in the different assays. Values of p< 0.05 were considered
statistically significant.
Supporting Information
S1 Fig. Schematic structure of smooth B. abortus Br-LPS. The O-polysaccharide is an un-
branched linear homopolymer of α-1,2-linked 4,6-dideoxy-4-formamido-D-mannopyranosyl
units (N-formylperosamine) with an average chain length of 96 to 100 glycosyl subunits [105].
The O-polysaccharide is linked to a core bifurcating oligosaccharide composed of βGlcN-6-
βGlcN-4-βGlcN(-6-βGlcN)-3-αMan(-6-αGlc)-5-KDO1(-2-KDO2)-Lipid A; branching from
KDO1 is αPerNFo-[-2PerNFo]n-2PerNF-2-αMan-3-αMan-3-βQuiNAc-4-βGlc-4-KDO2-
4-KDO1 [44]. The KDO1 is linked to the lipid A composed of a backbone of diaminoglucose
(DAG) disaccharide, substituted with phosphates (P) and amide and ester-linked long chain
saturated (C16:0 to C18:0) and hydroxylated (3-OH-C12:0 to 29-OH-C30:0) fatty acids [42,107].
Ketodeoxyoctulosonic acid (KDO), mannose (Man), Acetyl-quinovosamine (QuiN), glucose
(Glc).
(TIF)
S2 Fig. Neutralization of TLR4 does not protect against Br-LPS-induced PMN cell death.
Heparinized blood was incubated with Br-LPS (3 pmol/mL) alone or previously neutralized
with anti-TLR4 and PMN population gated and analyzed by Annexin V marker. Geometric
means of histograms displayed as relative units. Experiments were repeated at least three times.
(TIF)
S3 Fig. Br-LPS induces little activation of caspase 8 and 9 in lymphocytes.Heparinized
blood was incubated with 0.3 pmol/mL of Br-LPS or PBS for 30 minutes and stained with anti-
active caspase 8 or anti-active caspase 9. Lymphocyte population was gated by forward light
scatter and side light scatter parameters and analyzed for each caspase marker. Geometric
means of histograms are displayed as relative units. Experiments were repeated at least
three times.
(TIF)
S4 Fig. Cell death promoted by Br-LPS failed to induce NETosis. Isolated PMNs were stimu-
lated with PMA (40nM) or Br-LPS (3 pmol/mL). (A) NET formation induced by PMA, or (B)
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cell cytotoxicity induced by Br-LPS was analyzed under the fluorescent microscope. (C) Cell
morphology of PMA treated cells, or (D) Br-LPS treated cells were observed using phase con-
trast. NET formation is clearly seen in “A”, while in “B” cell death without NET formation is
observed. Microscope images are at 400 × magnification. Figure represents the outcome of a
single experiment. Similar results were obtained in repeated experiments by looking
NET spreading
(TIF)
S5 Fig. Brucella and Br-LPS induces PMNs DNA fragmentation. (A) Heparinized blood was
incubated with B. abortus-RFP for 2 hours (MOI 100). Red blood cells were lysed and total leu-
cocytes prepared, fixed and stained with APO-BrdU TUNEL Assay Kit according to manufac-
turer’s specifications. Cells were centrifuged and mounted with ProLong Gold Antifade
Reagent with DAPI. (a) B. abortus-RFP, (b) PMN DAPI staining (c) TUNEL positive nucleus
and (d) merged images. Images were cut from microscope field, contrasted and saturated using
Hue tool to obtain suitable color separation. Images were then merged using Adobe Photoshop
8 software. Microscope images are at 1000 × magnification. (B) Purified blood PMNs were in-
cubated with B. abortus (MOI 100) or Br-LPS (0.3 pmol/mL) in the presence or absence of a
pan-caspase inhibitor (Z-VAD-FMK) for one hour. Cycloheximide was used as a positive con-
trol. PMN DNA fragmentation was measured by Cellular DNA Fragmentation ELISA (Roche).
Values of p<0.01 () are indicated.
(TIF)
S6 Fig. Proposed model for the premature cell death of Brucella infected PMNs. After Bru-
cella invasion, the bacterium is readily phagocytized by resident PMNs [24] resisting the killing
mechanisms mediated by these leukocytes [31]. Once inside phagosomes, the bacterium re-
leases non-toxic Br-LPS, probably in the form of outer membrane fragments [75]. Then, the
Br-LPS fuses with the cell membrane of PMNs, binds to CD14 lipoprotein and is transported
inside the cytoplasm of PMNs within endocytic vacuoles. During this process, the Br-LPS does
not interact with TLR-4; then, avoiding activation of PMNs. In the course of this action,
NADPH oxidase is progressively recruited promoting the slow generation of controlled
amounts of ROS mediators. These effectors induce oxidative damage of nuclear DNA inducing
molecular fragmentation and the recruitment of Chek1 protein, which is the main responsible
for coordinating the DNA damage response at the initiation of the cell cycle. In PMNs −which
are non-dividing effector cells− Chek1, rather than arresting the cell cycle, may recruit cell
death executioner caspases which in course promote the activation of caspase-activated Dnases
(CAD), contributing to the damage of DNA. At the same time, some of the ROS effectors may
act as second messengers and induce the activation of caspases 5 and to minor extend caspase
4, but not caspase 1, excluding the participation of the inflammasome pathway. ROS may also
induce the recruitment of the RIP1 kinase/FADD cell death routes, caspase 8 and promote the
release of Ca++ to the cytosol. These mediators, will also recruit cell death executioner caspases
and together with ROS mediators trigger additional death effector mechanisms (e.g. activation
of calpains and cathepsins). Finally, the activation of the initiator caspase 9 of the intrinsic cell
death pathway will be activated downstream by caspase 8 contributing to the premature PMN
cell death mechanism. During this process, the infected PMNs expose “eat-me” signals (e.g.
phosphatidylserine) on the surface that promote their phagocytosis by Mϕ or DCs.
(TIF)
S7 Fig. PMN cell death modulation. After danger signal or PAMP recognition, PMNs become
activated, cell death delayed and inflammatory response promoted. Under noninfectious con-
ditions, PMNs die spontaneously and are phagocytized by DCs and MØ under non-
Brucella-Induced Neutrophil Cell Death
PLOS Pathogens | DOI:10.1371/journal.ppat.1004853 May 6, 2015 23 / 29
inflammatory conditions. Following PMNs ingestion of Brucella, PMNs are quickly primed for
cell death and phagocytized by DCs and MØ where Brucella replicates intensively under a
non-inflammatory environment.
(TIF)
S8 Fig. PMNs and lymphocytes gating strategy. (A) PMN or lymphocyte cell populations
were gated by forward light scatter and side light scatter parameters from total blood leucocyte
population. (B) GFP negative or GFP positive population (infected with B. abortus-GFP) were
selected and (C) analyzed for cell death by AquaDead and Annexin V markers.
(TIF)
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